Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Controlled release pharmaceutical or food formulation and process for its preparation

a technology of controlled release and food formulation, which is applied in the direction of drug compositions, amide active ingredients, plant/algae/fungi/lichens ingredients, etc., can solve the problems of loss of the effectiveness of the pharmaceutical or food form, unpredictability, and further unforeseeable alteration of the release kinetics, so as to achieve high reproducibility and improve the release profile

Active Publication Date: 2011-12-29
AZIENDE CHIMHE RIUNITE ANGELINI FRANCESCO A C R A F
View PDF4 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0028]Surprisingly, the Applicant has found that the mixture of a glycogen with a polysaccharide, preferably a cellulose or gum, in the presence of an active ingredient, makes it possible to obtain controlled release pharmaceutical or food formulations which overcome the disadvantages described above.
[0032]Moreover, the Applicant has also observed that the pharmaceutical formulation according to the present invention shows hardness and friability characteristics which are suitable for industrial production without requiring addition of the excipients conventionally used for this purpose, such as for example diluents, binders and / or plasticisers.
[0051]The Applicant has observed that the process of production according to the present invention is economically convenient, is readily suited to industrial application, offers high reproducibility and makes it possible to manufacture pharmaceutical forms such as for example tablets, or food forms such as for example supplements, with an improved release profile.

Problems solved by technology

A first disadvantage lies in the fact that the release profile often varies from the ideal profile of zero kinetics (that is release at a constant rate), being observed that there is initially a very high release rate which then decreases, or an initially very low release rate which then increases, or again a rate which varies unpredictably.
A second disadvantage lies in the fact that in order to obtain suitable hardness and friability characteristics in industrial production formulations often require the addition of further excipients which further unforeseeably alter release kinetics.
A third disadvantage lies in the fact that the active ingredient is not completely released and absorbed, in that the pharmaceutical or food form often retains even up to more than 20% w / w of the active ingredient present therein, thus bringing about a loss in the effectiveness of the pharmaceutical or food form and an increase in costs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Controlled release pharmaceutical or food formulation and process for its preparation
  • Controlled release pharmaceutical or food formulation and process for its preparation
  • Controlled release pharmaceutical or food formulation and process for its preparation

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Tablets 1-3 (Invention)

[0111]A series of tablets from 1 to 3 containing the ingredients in Table 1 were prepared using the following procedure. Excipient 2 and the glidant were mixed for approximately 2 minutes and passed through an 18 mesh sieve. Excipient 1 was first loaded into a mixer, followed by the active ingredient and finally the mixture of excipient 2 and glidant. The composition was mixed for approximately 10 minutes. Mixing was then interrupted, and the lubricant was added. After mixing for a further approximately 3 minutes the composition was discharged from the mixer and compressed in a tabletting machine.

[0112]The quantity of active ingredient, excipient 1 and excipient 2 were weighted in such a way as to give a ratio by weight between them of 3:1:1 for tablet 1, 3:1:2 for tablet 2 and 3:1:3 for tablet 3.

TABLE 1123Active ingredientParacetamol360300257Excipient 1Methocel K100M12010085.7Excipient 2Polglumyt120200257GlidantAerosil333LubricantPRUV999Polglum...

example 2

Preparation of Tablets 4-6 (Comparison)

[0116]A series of tablets from 4 to 6 containing the ingredients in Table 2 were prepared according to the same procedure as in Example 1.

TABLE 2456Active ingredientParacetamol360300257Excipient 1Methocel K100M12010085.7Excipient 2Avicel PH200120200257GlidantAerosil333LubricantPRUV999Avicel ®PH200: Microcrystalline cellulose having nominal dimensions of 180 μm, produced by FMC BioPolymer, USA

[0117]Tablets 4-6 were subjected to the same dissolution test as in Example 1 under the same conditions. The results of the dissolution test for tablets 4-6 are shown in FIG. 2.

example 3

Preparation of Tablets 7-9 (Comparison)

[0118]A series of tablets from 7 to 9 containing the ingredients in Table 3 were prepared according to the same procedure as in Example 1.

TABLE 3789Active ingredientParacetamol360300257Excipient 1Methocel K100M12010085.7Excipient 2Lactose120200257GlidantAerosil333LubricantPRUV999

[0119]Tablets 7-9 were subjected to the same dissolution test as in Example 1 under the same conditions. The results of the dissolution test for tablets 7-9 are shown in FIG. 3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Fractionaaaaaaaaaa
Percent by massaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a controlled release pharmaceutical or food formulation comprising at least one active pharmaceutical or food ingredient dispersed in a mixture of a glycogen with a polysaccharide, and the process for its preparation. The invention also relates to a slow release system represented by a mixture of a glycogen with a polysaccharide, and its use for the preparation of slow release pharmaceutical or food formulations.

Description

FIELD OF THE INVENTION[0001]This invention relates to a controlled release pharmaceutical or food formulation, and the process for its preparation.[0002]In particular, the invention relates to a controlled release pharmaceutical or food formulation comprising at least one pharmaceutical or food active ingredient dispersed in a mixture of a glycogen with a polysaccharide, and the process for its preparation.[0003]More particularly, the invention also relates to a controlled release system represented by a mixture of a glycogen with a polysaccharide.STATE OF THE ART[0004]Pharmaceutical forms or formulations for the administration of drugs contain auxiliary substances known as excipients in addition to the active pharmaceutical ingredient. These excipients are similarly included in food supplements which constitute a food formulation comprising a functional substance (vitamin, energy providing substance, protein, and so on), referred to below as a food active ingredient. In this descri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/197A61K31/167A61K31/497A61K31/495A61K31/5513A61K31/341A61K31/345A61K31/4015A61K31/4365A61K31/40A61K31/137A61K31/195A61K31/135A61K31/496A61K31/4439A61K31/485A61K31/422A61K31/405A61K31/4196A61K36/00A61K33/00A61K33/42A61K33/30A61K33/24A61K36/16A61K36/28A61K36/8962A61K36/45A61K31/375A61K31/07A61K31/519A61K31/59A61K31/122A61K31/455A61K31/7008A61K31/715A61K31/047A61K31/385A61K31/4045A61K36/38A61K36/324A61P43/00A61K31/192
CPCA61K9/2054A61K9/205A61P43/00A61K9/20A61K31/734
Inventor SELVA, STEFANOMARCHITTO, LEONARDOCIOTTOLI, GIOVANNI BATTISTARAGNI, LORELLARUSSO, VINCENZOLIBERATI, ELISA
Owner AZIENDE CHIMHE RIUNITE ANGELINI FRANCESCO A C R A F
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com